Similarly, TMZ therapy significantly increased the rate of single-cell conversions, and therapy-induced HIF1a and HIF2a seem to play key roles in allowing non-stem glioma cells to acquire stem-like traits [25]. Here, HIF1A is linked to central nervous system cancer.